Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Matthew D Galsky, Karen A Autio, Christopher R Cabanski, et al.
Journal for Immunotherapy of Cancer
|
January 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma
Eileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman, et al.
Plos One
|
March 16, 2018
Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes
Vonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Plos One
|
March 2, 2013
Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes
Vonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Science Advances
|
June 25, 2020
The clonal evolution of metastatic colorectal cancer
Ha X Dang, Bradley A Krasnick, Brian S White, et al.
Cancer Discovery
|
April 8, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Isabella C Glitza, Yongwoo David Seo, Christine N Spencer, et al.
The Lancet. Oncology
|
January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Archives of Pathology & Laboratory Medicine
|
May 16, 2012
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets
Juneko E Grilley-Olson, D Neil Hayes, Dominic T Moore, et al.
Cancer Immunology Research
|
January 7, 2026
IL-10R inhibition induces neutrophil tumoricidal activity
Danny N Khalil, Ricardo Gomez, Amit Regev, et al.
Nature Medicine
|
June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Lacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2025
Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Matthew D Galsky, Karen A Autio, Christopher R Cabanski, et al.
Journal for Immunotherapy of Cancer
|
January 30, 2026
Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma
Eileen M O'Reilly, Christopher R Cabanski, Jaclyn P Lyman, et al.
Plos One
|
March 16, 2018
Correction: Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes
Vonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Plos One
|
March 2, 2013
Molecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genes
Vonn Walter, Xiaoying Yin, Matthew D Wilkerson, et al.
Science Advances
|
June 25, 2020
The clonal evolution of metastatic colorectal cancer
Ha X Dang, Bradley A Krasnick, Brian S White, et al.
Cancer Discovery
|
April 8, 2024
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity
Isabella C Glitza, Yongwoo David Seo, Christine N Spencer, et al.
The Lancet. Oncology
|
January 2, 2021
CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study
Mark H O'Hara, Eileen M O'Reilly, Gauri Varadhachary, et al.
Archives of Pathology & Laboratory Medicine
|
May 16, 2012
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets
Juneko E Grilley-Olson, D Neil Hayes, Dominic T Moore, et al.
Cancer Immunology Research
|
January 7, 2026
IL-10R inhibition induces neutrophil tumoricidal activity
Danny N Khalil, Ricardo Gomez, Amit Regev, et al.
Nature Medicine
|
June 6, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
Lacey J Padrón, Deena M Maurer, Mark H O'Hara, et al.
Page
of 4